FDA clears Barostat option for EndoFLIP system

Crospon Medical Devices has received FDA clearance for the first use of its EndoFLIP system in gastro-enterology applications. The newly cleared Barostat software option extends the FDA-cleared uses for the EndoFLIP system beyond measurements taken during gastric band and sleeve gastrectomy bariatric surgery procedures, to now include pressure and dimension measurements taken in the oesophagus and as an adjunct to other methods in the comprehensive evaluation of patients with symptoms consistent with oesophageal sensory hypersensitivity. All new EndoFLIP systems will include the Barostat software option.

This article is tagged to:
Sector: Medical Devices
Geography: Ireland

Enter your details to read the full article

By submitting this form you are acknowledging that you have read and understood our Privacy Policy.